Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schott, R.
Right arrow Articles by Weitzenblum, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schott, R.
Right arrow Articles by Weitzenblum, E.
(Chest. 1999;115:1748-1749.)
© 1999 American College of Chest Physicians

Improvement of Pulmonary Hypertension After Liver Transplantation*

Roland Schott , MD; Ari Chaouat , MD; Anne Launoy , MD; Thierry Pottecher , MD and Emmanuel Weitzenblum , MD, FCCP

* From the Departments of Respiratory Medicine (Drs. Schott, Chaouat, and Weitzenblum) and Anesthesiology and Surgical Intensive Care (Drs. Launoy and Pottecher), University Hospital, Strasbourg, France.

Pulmonary hypertension at the end stage of chronic liver disease is not an uncommon situation. This association termed portopulmonary hypertension raises the question of the feasibility of performing orthotopic liver transplantation (OLT). In the case reported herein, there was a favorable outcome after OLT, even though the mean pulmonary artery pressure (MPAP) before transplantation was increased to 45 mm Hg. Before OLT, the cardiac index (CI) was considerably elevated (7.69 L/min/m2), giving evidence of a marked hyperdynamic circulatory state. The CI decreased significantly after OLT (3.38 L/min/m2), and this produced a significant decrease in the MPAP. Our observation suggests that portopulmonary hypertension due to a marked increase in the CI can be managed successfully by OLT.

Key Words: liver transplantation • portal hypertension • pulmonary hypertension




This article has been cited by other articles:


Home page
 Eur Respir JHome page
R. Rodriguez-Roisin, M.J. Krowka, Ph. Herve, M.B. Fallon, and on behalf of the ERS Task Force Pulmonary-Hepatic
Pulmonary-Hepatic vascular Disorders (PHD)
Eur. Respir. J., November 1, 2004; 24(5): 861 - 880.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Minder, M. Fischler, B. Muellhaupt, M.P. Zalunardo, R. Jenni, P-A. Clavien, and R. Speich
Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension
Eur. Respir. J., October 1, 2004; 24(4): 703 - 707.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. L. Rafanan, J. Maurer, A. C. Mehta, and R. Schilz
Progressive Portopulmonary Hypertension After Liver Transplantation Treated With Epoprostenol
Chest, November 1, 2000; 118(5): 1497 - 1500.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. Teramoto, T. Ishii, Y. Ouchi, A. Chaouat, E. Weitzenblum, and R. Schott
The Mechanism of Hypoxemia in Liver Disease With Pulmonary Hypertension
Chest, February 1, 2000; 117(2): 614 - 615.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.